Table 5.
RIFLESCr | RIFLESCr+UO | |
---|---|---|
No AKI | 200 (77%) | 144 (55%) |
Risk | 29 (11%) | 54 (21%) |
Injury | 14 (5%) | 36 (14%) |
Failure1) | 17 (7%) | 26 (10%) |
Total | 260 (100%) | 260 (100%) |
CVVH | 14 (5%) | 14 (5%) |
CVVH, continuous veno-venous hemofiltration; No AKI, patients without any occurrence of RIFLE criteria; RIFLESCr, RIFLE diagnosis based on RIFLE serum creatinine criteria only; RIFLESCr+UO, RIFLE diagnosis based on both serum creatinine and urine criteria. 1) Based on serum creatinine and urine criteria only, the initiation of CVVH not taken into account.